The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Azithromycin Reduces Airway Neutrophilia and Interleukin-8 in Patients with Bronchiolitis Obliterans Syndrome
Abstract
RATIONALE: Bronchiolitis obliterans syndrome (BOS) remains the leading cause of death after lung transplantation. Treatment is difficult, although azithromycin has recently been shown to improve FEV(1). The exact mechanism of action is unclear. HYPOTHESES: (1) Azithromycin reduces airway neutrophilia and interleukin (IL)-8 and (2) airway neutrophilia predicts the improvement in FEV(1). METHODS: Fourteen lung transplant patients with BOS (between BOS 0-p and BOS 3) were treated with azithromycin, in addition to their current immunosuppressive treatment. Before and 3 mo after azithromycin was introduced, bronchoscopy with bronchoalveolar lavage (BAL) was performed for cell differentiation and to measure IL-8 and IL-17 mRNA ratios. RESULTS: The FEV(1) increased from 2.36 (+/- 0.82 L) to 2.67 L (+/- 0.85 L; p = 0.007), whereas the percentage of BAL neutrophilia decreased from 35.1 (+/- 35.7%) to 5.7% (+/- 6.5%; p = 0.0024). There were six responders to azithromycin (with an FEV(1) increase of > 10%) and eight nonresponders. Using categorical univariate linear regression analysis, the main significant differences in characteristics between responders and nonresponders were the initial BAL neutrophilia (p < 0.0001), IL-8 mRNA ratio (p = 0.0009), and the postoperative day at which azithromycin was started (p = 0.036). There was a significant correlation between the initial percentage of BAL neutrophilia and the changes in FEV(1) after 3 mo (r = 0.79, p = 0.0019). CONCLUSION: Azithromycin significantly reduces airway neutrophilia and IL-8 mRNA in patients with BOS. Responders have a significantly higher BAL neutrophilia and IL-8 compared with nonresponders and had commenced treatment earlier after transplantation. BAL neutrophilia can be used as a predictor for the FEV(1) response to azithromycin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standardization of Spirometry — 1987 Update
Buist, A. S. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1073 · Cited by 3,266
Standardization of Spirometry—1987 Update
(1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1285 · Cited by 2,315
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
Estenne, M., Maurer, J. R., Boehler, A., Egan, J. J., Frost, A., Hertz, M., Mallory, G. B., Snell, G. I., & Yousem, S. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00398-4 · Cited by 1,274
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study
Gerhardt, S. G., McDyer, J. F., Girgis, R. E., Conte, J. V., Yang, S. C., & Orens, J. B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200212-1424bc · Cited by 306
Trulock, E. P., Edwards, L. B., Taylor, D. O., Boucek, M. M., Keck, B. M., & Hertz, M. I. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2005.05.019 · Cited by 256
Neutrophils, interleukin-17A and lung disease
Lindén, A., Laan, M., & Anderson, G. P. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00032904 · Cited by 252
Azithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome
Yates, B., Murphy, D. M., Forrest, I. A., Ward, C., Rutherford, R. M., Fisher, A. J., Lordan, J. L., Dark, J. H., & Corris, P. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1537oc · Cited by 228
The role of interleukin-17 during acute rejection after lung transplantation
Vanaudenaerde, B. M., Dupont, L. J., Wuyts, W. A., Verbeken, E. K., Meyts, I., Bullens, D. M., Dilissen, E., Luyts, L., Van Raemdonck, D. E., & Verleden, G. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00019405 · Cited by 183
Self-citationMacrolide Treatment Decreased the Size of Nasal Polyps and IL-8 Levels in Nasal Lavage
Yamada, T., Fujieda, S., Mori, S., Yamamoto, H., & Saito, H. (2000) · American Journal of Rhinology · doi:10.2500/105065800782102717 · Cited by 167
Gastroesophageal Reflux as a Reversible Cause of Allograft Dysfunction After Lung Transplantation
Palmer, S. M., Miralles, A. P., Howell, D. N., Brazer, S. R., Tapson, V. F., & Davis, R. D. (2000) · Chest · doi:10.1378/chest.118.4.1214 · Cited by 161
Prause, O., Laan, M., Lötvall, J. O., & Lindén, A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01341-4 · Cited by 139
Azithromycin Blocks Neutrophil Recruitment in Pseudomonas Endobronchial Infection
Tsai, W. C., Rodriguez, M. L., Young, K. S., Deng, J. C., Thannickal, V. J., Tateda, K., Hershenson, M. B., & Standiford, T. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-200oc · Cited by 138
Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.
Weber, F. H., Richards, R. D., & McCallum, R. W. (1993) · PubMed · Cited by 132
Riise, G. C., Williams, A., Kjellström, C., Scherstén, H., Andersson, B., & Kelly, F. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12010082 · Cited by 126
Neutrophil Recruitment by Interleukin-17 into Rat Airways In Vivo : Role of Tachykinins
Hoshino, H., Lötvall, J. O., Skoogh, B., & Lindén, A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9806008 · Cited by 95
Vanaudenaerde, B. M., Wuyts, W. A., Dupont, L., Raemdonck, D. E. V., Demedts, M., & Verleden, G. M. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)01234-2 · Cited by 91
Self-citationWilliams, T. J., & Verleden, G. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2506011 · Cited by 22
Self-citationBronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment
Verleden, G. M., Bankier, A., Boehler, A., Corris, P. A., Dupont, L., Estenne, M., Fischer, S., Lerut, A., Reichenspurner, H. C., & and other co-authors of Working Group 1 (2004) · European Respiratory Society eBooks · doi:10.1183/1025448x.00029002 · Cited by 10
Self-citation
Cited by
Verleden, G. M., Glanville, A. R., Lease, E. D., Fisher, A. J., Calabrese, F., Corris, P. A., Ensor, C. R., Gottlieb, J., Hachem, R. R., Lama, V., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.03.009 · Cited by 952
Self-citationMechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 708
Azithromycin: Mechanisms of action and their relevance for clinical applications
Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.003 · Cited by 661
Self-citationMeyer, K. C., Raghu, G., Verleden, G. M., Corris, P. A., Aurora, P., Wilson, K. C., Brozek, J., Glanville, A. R., & the ISHLT/ATS/ERS BOS Task Force Committee (2014) · European Respiratory Journal · doi:10.1183/09031936.00107514 · Cited by 555
Self-citationA new classification system for chronic lung allograft dysfunction
Verleden, G. M., Raghu, G., Meyer, K. C., Glanville, A. R., & Corris, P. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.10.022 · Cited by 503
Self-citation
Metadata
- Authors
- Verleden, G. M., Vanaudenaerde, B. M., Dupont, L. J., & Van Raemdonck, D. E.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-01
- Volume
- 174
- Issue
- 5
- Pages
- 566-570
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2038257815
- Cited by
- 296
- References
- 19
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.